The Chattanoogan |
Erlanger Announces Appointment Of Asad Zaman, MHA, As Transplant Service …
The Chattanoogan … the overall operation of end-stage renal care in our region. As the region’s only kidney transplant program, Asad will focus on providing more outreach to surrounding communities and educating patients about their local option for kidney … |
MediciNova Announces Positive Results in NASH Mouse Model With MN-001 …NASDAQLiver transplantation is the only treatment for advanced cirrhosis with liver failure. At this time, there is no treatment for NASH. About MediciNova. MediciNova, Inc. is a …
MediciNova Announces Positive Results in NASH Mouse Model With MN-001 …BenzingaLiver transplantation is the only treatment for advanced cirrhosis with liver failure. At this time, there is no treatment for NASH. About MediciNova. MediciNova, Inc. is …
|
Jahi McMath is Alive
American Thinker In the wake of early enthusiasm for heart transplantation, “brain death” legislation was passed in the 1970’s in all fifty states in the USA, to allow for death to be declared by neurological criteria, rather than the cessation of cardiac activity … |
|
University of Maryland Study: Two-Sizes-Too-Small ‘Grinch’ Effect Hampers …
UMB News “Heart transplantation has made great strides in recent years; now, thanks to this research, clinicians have a new calculus that promises better donor-recipient matching and better-functioning hearts,” says E. Albert Reece, M.D., Ph.D., M.B.A., vice … |
Mismatched Organ Size Tied to Worse Heart Transplant OutcomeMonthly Prescribing ReferenceNoting that organ allocation in heart transplantation currently incorporates only body weight, Robert M. Reed, MD, from the University of Maryland School of Medici…
Mismatched Organ Size Tied to Worse Heart Transplant OutcomeDoctors LoungeNoting that organ allocation in heart transplantation currently incorporates only body weight, Robert M. Reed, M.D., from the University of Maryland School of Medicine in Baltimo…
Pharmalink Completes Enrolment of Patients into Phase IIB Clinical Study …Sacramento Bee… or kidney transplantation. IgA nephropathy accounts for 10% of renal transplants among patients with primary glomerulonephritis in the US and between 7-20% of…
Galectin Therapeutics Announces Completion of Enrollment in First Cohort of …MarketWatchOver time, patients with fatty liver disease can develop fibrosis, or scarring of the liver, and it is estimated that as many as three million individuals will de…
Galectin Therapeutics Inc : Galectin Therapeutics Announces Completion of …4-traders (press release)Over time, patients with fatty liver disease can develop fibrosis, or scarring of the liver, and it is estimated that as many as three million individ…